Vanderbilt-Ingrim Cancer Center

Nashville, Tennessee 37232

2 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Follicular Lymphoma, Large B-cell Lymphoma, Mantle Cell Lymphoma

Studies at this site

• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel — Available (expanded access)